China Shineway Pharmaceutical Group Limited

PINK:CSWYF USA Drug Manufacturers - Specialty & Generic
Market Cap
$758.42 Million
Market Cap Rank
#14841 Global
#5908 in USA
Share Price
$1.00
Change (1 day)
+0.00%
52-Week Range
$1.00 - $1.00
All Time High
$1.00
About

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules … Read more

China Shineway Pharmaceutical Group Limited (CSWYF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2024: 0.119x

Based on the latest financial reports, China Shineway Pharmaceutical Group Limited (CSWYF) has a cash flow conversion efficiency ratio of 0.119x as of December 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($885.51 Million) by net assets ($7.47 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

China Shineway Pharmaceutical Group Limited - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how China Shineway Pharmaceutical Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

China Shineway Pharmaceutical Group Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China Shineway Pharmaceutical Group Limited ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for China Shineway Pharmaceutical Group Limited (2015–2024)

The table below shows the annual cash flow conversion efficiency of China Shineway Pharmaceutical Group Limited from 2015 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $7.47 Billion $963.13 Million 0.129x -9.04%
2023-12-31 $991.63 Million $140.62 Million 0.142x -27.15%
2022-12-31 $917.31 Million $178.56 Million 0.195x +54.34%
2021-12-31 $952.62 Million $120.14 Million 0.126x +13.14%
2020-12-31 $917.23 Million $102.25 Million 0.111x +43.50%
2019-12-31 $837.07 Million $65.03 Million 0.078x -30.28%
2018-12-31 $839.80 Million $93.57 Million 0.111x +5.51%
2017-12-31 $905.23 Million $95.59 Million 0.106x -29.68%
2016-12-31 $825.35 Million $123.94 Million 0.150x +0.39%
2015-12-31 $829.82 Million $124.13 Million 0.150x --